152 related articles for article (PubMed ID: 15785312)
1. Survival patterns for the top four cancers in Canada: the effects of age, region and period.
Ugnat AM; Xie L; Semenciw R; Waters C; Mao Y
Eur J Cancer Prev; 2005 Apr; 14(2):91-100. PubMed ID: 15785312
[TBL] [Abstract][Full Text] [Related]
2. Evaluating factors associated with unknown SEER Summary Stage 2000 derived from collaborative stage at central registry level.
Hsieh MC; Yu Q; Wu XC; Wohler B; Fan Y; Qiao B; Jemal A; Ajani UA
J Registry Manag; 2012; 39(3):101-6. PubMed ID: 23443453
[TBL] [Abstract][Full Text] [Related]
3. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
[TBL] [Abstract][Full Text] [Related]
4. Trends in in-patient hospital utilization and surgical procedures for breast, prostate, lung and colorectal cancers in Canada.
Neutel CI; Gao RN; Wai E; Gaudette LA
Cancer Causes Control; 2005 Dec; 16(10):1261-70. PubMed ID: 16215877
[TBL] [Abstract][Full Text] [Related]
5. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
Nilssen Y; Brustugun OT; Eriksen MT; Haug ES; Naume B; Møller B
BMC Cancer; 2020 May; 20(1):488. PubMed ID: 32473650
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of the four major cancers in South Dakota.
Clarke J
S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
[TBL] [Abstract][Full Text] [Related]
7. Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.
Cho H; Mariotto AB; Mann BS; Klabunde CN; Feuer EJ
Am J Epidemiol; 2013 Aug; 178(3):339-49. PubMed ID: 23825168
[TBL] [Abstract][Full Text] [Related]
8. Age-standardized cancer-incidence trends in Canada, 1971-2015.
Brenner DR; Ruan Y; Shaw E; O'Sullivan D; Poirier AE; Heer E; Villeneuve PJ; Walter SD; Friedenreich CM; Smith L; De P
CMAJ; 2019 Nov; 191(46):E1262-E1273. PubMed ID: 31740536
[TBL] [Abstract][Full Text] [Related]
9. Cancer in Canada: Stage at diagnosis.
Bryan S; Masoud H; Weir HK; Woods R; Lockwood G; Smith L; Brierley J; Gospodarowicz M; Badets N
Health Rep; 2018 Dec; 29(12):21-25. PubMed ID: 30566206
[TBL] [Abstract][Full Text] [Related]
10. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.
Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF
Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835
[TBL] [Abstract][Full Text] [Related]
11. Five-year relative survival from prostate, breast, colorectal and lung cancer.
Ellison LF; Gibbons L;
Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
[TBL] [Abstract][Full Text] [Related]
12. A Medicare-Associated Spike in U.S. Cancer Rates at Age 65, 2000-2010.
Boscoe FP; Pradhan E
Public Health Rep; 2015; 130(4):343-8. PubMed ID: 26345512
[TBL] [Abstract][Full Text] [Related]
13. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program.
Mettlin CJ; Menck HR; Winchester DP; Murphy GP
Cancer; 1997 May; 79(10):2052-61. PubMed ID: 9149035
[TBL] [Abstract][Full Text] [Related]
14. Impact of reporting delay and reporting error on cancer incidence rates and trends.
Clegg LX; Feuer EJ; Midthune DN; Fay MP; Hankey BF
J Natl Cancer Inst; 2002 Oct; 94(20):1537-45. PubMed ID: 12381706
[TBL] [Abstract][Full Text] [Related]
15. Breast, lung and colorectal cancer incidence and survival in South Thames Region, 1987-1992: the effect of social deprivation.
Pollock AM; Vickers N
J Public Health Med; 1997 Sep; 19(3):288-94. PubMed ID: 9347452
[TBL] [Abstract][Full Text] [Related]
16. Google as a cancer control tool in Queensland.
Huang X; Baade P; Youlden DR; Youl PH; Hu W; Kimlin MG
BMC Cancer; 2017 Dec; 17(1):816. PubMed ID: 29202718
[TBL] [Abstract][Full Text] [Related]
17. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis.
Gondos A; Arndt V; Holleczek B; Stegmaier C; Ziegler H; Brenner H
Int J Cancer; 2007 Jul; 121(2):395-400. PubMed ID: 17372898
[TBL] [Abstract][Full Text] [Related]
18. Age- and time-dependent changes in cancer incidence among immigrants to Sweden: colorectal, lung, breast and prostate cancers.
Mousavi SM; Fallah M; Sundquist K; Hemminki K
Int J Cancer; 2012 Jul; 131(2):E122-8. PubMed ID: 22052616
[TBL] [Abstract][Full Text] [Related]
19. Urinary 8-isoprostane levels and occurrence of lung, colorectal, prostate, breast and overall cancer: Results from a large, population-based cohort study with 14 years of follow-up.
Gào X; Brenner H; Holleczek B; Cuk K; Zhang Y; Anusruti A; Xuan Y; Xu Y; Schöttker B
Free Radic Biol Med; 2018 Aug; 123():20-26. PubMed ID: 29778463
[TBL] [Abstract][Full Text] [Related]
20. Long-term cancer patient survival in the United States.
Wingo PA; Ries LA; Parker SL; Heath CW
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):271-82. PubMed ID: 9568781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]